Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

NEIL C NAGARIA

Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology

NPI
1760401749
CMS profile
79145
Location
TOMS RIVER, NJ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$1,684.63

108 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,684.63 108

By paying entity

PY2022 · entire year · sorted by reported total

Page 3 of 3; records 101–108 of 108 matching records. This page contains 8 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

NEIL C NAGARIA

NPI 1760401749 · CMS profile ID 79145

Allopathic & Osteopathic Physicians / Internal Medicine / Gastroenterology

TOMS RIVER, NJ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–108 of 108 matching records. This page contains 8 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1760401749?year=2022&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
NEIL C NAGARIA, NPI 1760401749, CMS profile ID 79145. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–108 of 108 matching records. This page contains 8 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1760401749?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). NEIL C NAGARIA, NPI 1760401749, CMS profile ID 79145. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–108 of 108 matching records. This page contains 8 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1760401749?year=2022&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
NEIL C NAGARIA, NPI 1760401749, CMS profile ID 79145, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–108 of 108 matching records. This page contains 8 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1760401749?year=2022&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

108 matching records · $1,684.63 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 108 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–108 of 108.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
RedHill Biopharma Inc. $12.6701/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 902938445 CMS
QOL Medical, LLC $12.3201/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 904148639 CMS
ABBVIE INC. $12.8601/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 891228411 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $9.5201/18/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 959892877 CMS
Celgene Corporation $13.6701/14/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932778553 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.1801/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 959613987 CMS
Takeda Pharmaceuticals U.S.A., Inc. $14.1301/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 956219609 CMS
Merck Sharp & Dohme LLC $14.8701/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944559381 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $432.85 17
PY2020 $507.38 31
PY2021 $1,776.42 114
PY2022 $1,684.63 108
PY2023 $1,893.13 108
PY2024 $10,936.54 110
PY2025 $57,443.06 209

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $115,686.88 38
PY2024 Principal investigator $76,470.00 20
PY2023 Principal investigator $175,072.00 20

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

38 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Genentech, Inc. $276.00 11/26/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211665258
Principal investigator 1 Genentech, Inc. $138.00 11/26/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211665292
Principal investigator 1 Genentech, Inc. $4,340.00 11/21/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211665266
Principal investigator 1 Bausch Health US, LLC $1,273.00 10/06/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224847005
Principal investigator 1 Bausch Health US, LLC $1,370.00 10/06/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224847019
Principal investigator 1 Bausch Health US, LLC $1,273.00 10/06/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224847023
Principal investigator 1 Genentech, Inc. $414.00 10/01/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211665188
Principal investigator 1 Genentech, Inc. $3,400.00 09/24/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211665109
Principal investigator 1 Genentech, Inc. $2,000.00 09/05/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211665033
Principal investigator 1 Bausch Health US, LLC $1,709.00 09/03/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224846803
Principal investigator 1 Bausch Health US, LLC $2,175.00 09/03/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224846832
Principal investigator 1 Genentech, Inc. $909.18 08/20/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211664999
Principal investigator 1 Bausch Health US, LLC $1,500.00 08/14/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224846836
Principal investigator 1 Bausch Health US, LLC $4,000.00 08/14/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224846877
Principal investigator 1 Genentech, Inc. $15,624.00 08/01/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211664972
Principal investigator 1 Bausch Health US, LLC $414.00 07/23/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224846773
Principal investigator 1 Bausch Health US, LLC $1,273.00 07/23/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224846817
Principal investigator 1 Bausch Health US, LLC $1,273.00 07/23/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224846865
Principal investigator 1 Bausch Health US, LLC $1,597.00 07/07/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224846781
Principal investigator 1 Bausch Health US, LLC $1,273.00 07/07/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224846855
Principal investigator 1 Genentech, Inc. $151.00 06/06/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211664886
Principal investigator 1 Bausch Health US, LLC $414.00 06/02/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224846906
Principal investigator 1 Bausch Health US, LLC $1,273.00 06/02/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224846933
Principal investigator 1 Genentech, Inc. $233.18 05/21/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211664830
Principal investigator 1 Genentech, Inc. $45,178.00 05/16/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211664841
Principal investigator 1 Bausch Health US, LLC $1,652.00 05/02/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224846994
Principal investigator 1 Bausch Health US, LLC $414.00 04/02/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224846902
Principal investigator 1 Bausch Health US, LLC $1,273.00 04/02/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224846913
Principal investigator 1 Bausch Health US, LLC $1,597.00 03/07/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224846627
Principal investigator 1 Genentech, Inc. $716.07 02/21/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211664648
Principal investigator 1 Genentech, Inc. $1,092.75 02/19/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211664586
Principal investigator 1 Genentech, Inc. $309.89 02/12/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211664562
Principal investigator 1 Bausch Health US, LLC $414.00 02/07/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224846694
Principal investigator 1 Bausch Health US, LLC $1,273.00 02/07/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224846718
Principal investigator 1 Bausch Health US, LLC $1,273.00 02/07/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224846728
Principal investigator 1 Genentech, Inc. $285.81 02/05/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211664530
Principal investigator 1 Genentech, Inc. $10,142.00 01/14/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Roche Cancer Screening Collection Study No dispute reported 06/30/2026 1211664582
Principal investigator 1 Bausch Health US, LLC $1,764.00 01/08/2025 Non-covered Recipient Entity
The Clinical Trials Network LLC
Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) No dispute reported 06/30/2026 1224846711